Gene · 140767
Papers3,844
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,844
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phage based vaccine: A novel strategy in prevention and treatment. | Heliyon | 2023 | 37809683 | PubTator, text mining | PubMed |
| HIV-1 neutralizing antibodies provide sterilizing immunity by blocking infection of the first cells. | Cell Rep Med | 2023 | 37804829 | PubTator, text mining | PubMed |
| NK cells from Men Who Have Sex with Men at high risk for HIV-1 infection exhibit higher effector capacity. | Sci Rep | 2023 | 37798386 | PubTator, text mining | PubMed |
| Activation of the JNK/COX-2/HIF-1α axis promotes M1 macrophage via glycolytic shift in HIV-1 infection. | Life Sci Alliance | 2023 | 37798121 | PubTator, text mining | PubMed |
| Resting-state EEG dynamics help explain differences in response control in ADHD: Insight into electrophysiological mechanisms and sex differences. | PLoS One | 2023 | 37796795 | PubTator, text mining | PubMed |
| Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics. | J Virol | 2023 | 37796123 | PubTator, text mining | PubMed |
| BoDV-1 Infection in Children and Adolescents: A Systematic Review and Meta-Analysis. | Pediatr Rep | 2023 | 37755407 | PubTator, text mining | PubMed |
| Development of a Multiplex HIV/TB Diagnostic Assay Based on the Microarray Technology. | Biosensors (Basel) | 2023 | 37754128 | PubTator, text mining | PubMed |
| Generation of Antibodies Selectively Recognizing Epitopes in a Formaldehyde-Fixed Cell-Surface Antigen Using Virus-like Particle Display and Hybridoma Technology. | Antibodies (Basel) | 2023 | 37753971 | PubTator, text mining | PubMed |
| Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies. | bioRxiv | 2023 | 37745449 | PubTator, text mining | PubMed |
| KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir. | Cell Rep Med | 2023 | 37741278 | PubTator, text mining | PubMed |
| Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing. | J Extracell Vesicles | 2023 | 37723839 | PubTator, text mining | PubMed |
| Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells. | Cell Host Microbe | 2023 | 37708853 | PubTator, text mining | PubMed |
| On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine. | J Virol | 2023 | 37706687 | PubTator, text mining | PubMed |
| Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection. | AIDS | 2023 | 37702421 | PubTator, text mining | PubMed |
| The HIV-2 OGH double reporter virus shows that HIV-2 is less cytotoxic and less sensitive to reactivation from latency than HIV-1 in cell culture. | J Virus Erad | 2023 | 37701289 | PubTator, text mining | PubMed |
| Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones. | J Clin Invest | 2023 | 37698927 | PubTator, text mining | PubMed |
| Delineating mouse β-cell identity during lifetime and in diabetes with a single cell atlas. | Nat Metab | 2023 | 37697055 | PubTator, text mining | PubMed |
| Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo. | Mol Ther Methods Clin Dev | 2023 | 37693944 | PubTator, text mining | PubMed |
| HIV-1 binds dynein directly to hijack microtubule transport machinery. | bioRxiv | 2023 | 37693451 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140767/papers?page=8